La Salvia, A.; Sesti, F.; Grinzato, C.; Mazzilli, R.; Tarsitano, M.G.; Giannetta, E.; Faggiano, A.
Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review. Pharmaceuticals 2021, 14, 1039.
https://doi.org/10.3390/ph14101039
AMA Style
La Salvia A, Sesti F, Grinzato C, Mazzilli R, Tarsitano MG, Giannetta E, Faggiano A.
Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review. Pharmaceuticals. 2021; 14(10):1039.
https://doi.org/10.3390/ph14101039
Chicago/Turabian Style
La Salvia, Anna, Franz Sesti, Chiara Grinzato, Rossella Mazzilli, Maria Grazia Tarsitano, Elisa Giannetta, and Antongiulio Faggiano.
2021. "Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review" Pharmaceuticals 14, no. 10: 1039.
https://doi.org/10.3390/ph14101039
APA Style
La Salvia, A., Sesti, F., Grinzato, C., Mazzilli, R., Tarsitano, M. G., Giannetta, E., & Faggiano, A.
(2021). Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review. Pharmaceuticals, 14(10), 1039.
https://doi.org/10.3390/ph14101039